Advertisement.

OCGN Projected Dividend Yield

Ocugen Inc ( NASDAQ : OCGN )

Ocugen is a biopharmaceutical company focused on gene and cell therapies, biologics, and vaccines to improve global health. Its pipeline includes a modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. Ocugen is developing OCU400, OCU410, and OCU410ST for inherited retinal diseases like retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease, and multifactorial diseases such as dry age-related macular degeneration and geographic atrophy. Co. is working on an inhalation-based mucosal vaccine platform with OCU500 (COVID-19 vaccine), OCU510 (seasonal flu vaccine), and OCU520 (combination flu and COVID-19 vaccine).

20 YEAR PERFORMANCE RESULTS

OCGN Dividend History Detail
OCGN Dividend News
OCGN Competitors News

# of Shares: 0

Closing Price: 0.86

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000